Free Trial
LON:GNS

Genus (GNS) Share Price, News & Analysis

Genus logo
GBX 2,605 -35.00 (-1.33%)
As of 08/29/2025 12:14 PM Eastern

About Genus Stock (LON:GNS)

Key Stats

Today's Range
2,600
2,655
50-Day Range
1,924
2,715
52-Week Range
1,424
2,760
Volume
92,052 shs
Average Volume
222,540 shs
Market Capitalization
£1.71 billion
P/E Ratio
N/A
Dividend Yield
0.01%
Price Target
GBX 2,725
Consensus Rating
Buy

Company Overview

Genus Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
4th Percentile Overall Score

GNS MarketRank™: 

Genus scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Genus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Genus has only been the subject of 2 research reports in the past 90 days.

  • Read more about Genus' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Genus is -42,016.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Genus is -42,016.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Genus has a PEG Ratio of 2.87. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Genus has a P/B Ratio of 3.15. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for GNS.
  • Dividend Yield

    Genus pays a meaningful dividend of 1.21%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Genus does not have a long track record of dividend growth.

  • Read more about Genus' dividend.
  • Short Interest

    There is no current short interest data available for GNS.
  • Search Interest

    Only 5 people have searched for GNS on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Genus insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.59% of the stock of Genus is held by insiders.

  • Percentage Held by Institutions

    63.38% of the stock of Genus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Genus' insider trading history.
Receive GNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genus and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GNS Stock News Headlines

Genus (LON:GNS) Price Target Raised to GBX 2,900 at Shore Capital
Those who invested in Genus (LON:GNS) a year ago are up 50%
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).tc pixel
Genus Stock Price History
See More Headlines

GNS Stock Analysis - Frequently Asked Questions

Genus' stock was trading at GBX 1,550 at the beginning of the year. Since then, GNS stock has increased by 68.1% and is now trading at GBX 2,605.

Genus plc (LON:GNS) posted its quarterly earnings data on Thursday, February, 27th. The company reported $39.80 EPS for the quarter. Genus had a net margin of 1.18% and a trailing twelve-month return on equity of 1.41%.
Read the conference call transcript
.

Shares of GNS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genus investors own include Meta Platforms (META), Lloyds Banking Group (LLOY), Rolls-Royce Holdings plc (RR.L), AstraZeneca (AZN), Barclays (BARC), BP (BP) and Clinigen Group (CLIN).

Company Calendar

Last Earnings
2/27/2025
Today
8/31/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Personal Services
Current Symbol
LON:GNS
CIK
N/A
Fax
N/A
Employees
480
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 2,900
Low Price Target
GBX 2,550
Potential Upside/Downside
+4.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX (0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
36.71
P/E Growth
2.87
Net Income
£7.87 million
Net Margins
1.18%
Pretax Margin
N/A
Return on Equity
1.41%
Return on Assets
3.31%

Debt

Debt-to-Equity Ratio
53.12
Current Ratio
1.80
Quick Ratio
1.08

Sales & Book Value

Annual Sales
£671.60 million
Price / Sales
2.55
Cash Flow
GBX 51.52 per share
Price / Cash Flow
50.56
Book Value
GBX 827.95 per share
Price / Book
3.15

Miscellaneous

Outstanding Shares
65,693,000
Free Float
N/A
Market Cap
£1.71 billion
Optionable
Not Optionable
Beta
0.37
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (LON:GNS) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners